127 related articles for article (PubMed ID: 38156851)
21. Platinum complex with pyrimidine- and morpholine-based ligand: synthesis, spectroscopic, DFT, TDDFT, catalytic reduction,
Sankarganesh M; Vijay Solomon R; Dhaveethu Raja J
J Biomol Struct Dyn; 2021 Feb; 39(3):1055-1067. PubMed ID: 32036758
[TBL] [Abstract][Full Text] [Related]
22. Antiproliferative and Pro-Apoptotic Effects of Thiazolo[3,2-b][1,2,4]triazoles in Breast and Cervical Cancer Cells.
Khan I; Zaib S; Javed M; Rashid F; Iqbal J; Ibrar A
Anticancer Agents Med Chem; 2021 Oct; 21(16):2181-2191. PubMed ID: 33573578
[TBL] [Abstract][Full Text] [Related]
23. Revelation of potential bioactive water-soluble Boc-L-valine and imidazole appended metal complexes {M = Co(II), Cu(II) & Zn(II)}: synthesis, characterization, ct-DNA binding, pBR322 cleavage, SOD mimetic, and cytotoxicity studies.
Akhter S; Khursheed S; Arjmand F; Tabassum S
Dalton Trans; 2023 Apr; 52(16):5141-5154. PubMed ID: 36961247
[TBL] [Abstract][Full Text] [Related]
24. Pharmacophore hybrid approach of new modulated bis-diimine Cu(II)/Zn(II) complexes based on 5-chloro Isatin Schiff base derivatives: Synthesis, spectral studies and comparative biological assessment.
Shakir M; Hanif S; Sherwani MA; Mohammad O; Azam M; Al-Resayes SI
J Photochem Photobiol B; 2016 Apr; 157():39-56. PubMed ID: 26882291
[TBL] [Abstract][Full Text] [Related]
25. New platinum (II) complexes based on schiff bases: synthesis, specification, X-ray structure, ADMET, DFT, molecular docking, and anticancer activity against breast cancer.
Eslami Moghadam M; Hasanzadeh Esfahani M; Behzad M; Zolghadri S; Ramezani N; Azadi Y
J Biol Inorg Chem; 2023 Aug; 28(5):519-529. PubMed ID: 37452868
[TBL] [Abstract][Full Text] [Related]
26. Design, Synthesis, and Anti-Cervical Cancer and Reversal of Tumor Multidrug Resistance Activity of Novel Nitrogen-Containing Heterocyclic Chalcone Derivatives.
Yang Z; Liu ZY; Ablise M; Maimaiti A; Mutalipu Z; Alimujiang Y; Aihaiti A
Molecules; 2023 Jun; 28(11):. PubMed ID: 37299013
[TBL] [Abstract][Full Text] [Related]
27. Investigation on the interaction of newly designed potential antibacterial Zn(II) complexes with CT-DNA and HSA.
Mansouri-Torshizi H; Khosravi F; Ghahghaei A; Shahraki S; Zareian-Jahromi S
J Biomol Struct Dyn; 2018 Aug; 36(10):2713-2737. PubMed ID: 28768466
[TBL] [Abstract][Full Text] [Related]
28. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
29. Bio-active mixed ligand Cu(II) and Zn(II) complexes of pyrimidine derivative Schiff base: DFT calculation, antimicrobial, antioxidant, DNA binding, anticancer and molecular docking studies.
Revathi N; Sankarganesh M; Dhaveethu Raja J; Vinoth Kumar GG; Sakthivel A; Rajasekaran R
J Biomol Struct Dyn; 2021 May; 39(8):3012-3024. PubMed ID: 32329409
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization, in silico ADMET prediction, and protein binding analysis of a novel zinc(II) Schiff-base complex: Application of multi-spectroscopic and computational techniques.
Shahraki S; Shiri F; Saeidifar M
J Biomol Struct Dyn; 2018 May; 36(7):1666-1680. PubMed ID: 28604250
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, spectral characterization, DNA interaction, anticancer and molecular docking studies on some transition metal complexes with bidentate ligand.
Dhanaraj CJ; Hassan IU; Johnson J; Joseph J; Joseyphus RS
J Photochem Photobiol B; 2016 Sep; 162():115-124. PubMed ID: 27367456
[TBL] [Abstract][Full Text] [Related]
32. Novel amodiaquine analogues to treat cervical cancer and microbial infection in the future.
Islam S; Shahzad SA; Hassan Bin Asad MH; Mannan A
Future Med Chem; 2023 Dec; 15(23):2165-2179. PubMed ID: 37982232
[No Abstract] [Full Text] [Related]
33. Synthesis, characterization, molecular docking studies of Mn(II)Prolinedithiocarbamate and its potential as anticancer agents.
Jarre S; Raya I; Prihantono ; Santi S
Mol Divers; 2024 Apr; 28(2):889-900. PubMed ID: 36913052
[TBL] [Abstract][Full Text] [Related]
34. Spectroscopic evaluation of Zn (II) complexes with drug analogues: Interactions with BSA and the pH effect on the drug-Zn (II) system.
Vlasiou MC; Pafiti KS
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Nov; 241():118641. PubMed ID: 32622047
[TBL] [Abstract][Full Text] [Related]
35. Preparation, Spectroscopic Characterization, Theoretical Investigations, and In Vitro Anticancer Activity of Cd(II), Ni(II), Zn(II), and Cu(II) Complexes of 4(3
Ashok UP; Kollur SP; Anil N; Arun BP; Jadhav SN; Sarsamkar S; Helavi VB; Srinivasan A; Kaulage S; Veerapur R; Al-Rashed S; Syed A; Ortega-Castro J; Frau J; Flores-Holguín N; Glossman-Mitnik D
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339433
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, characterization, thermal properties, antimicrobial evaluation, ADMET study, and molecular docking simulation of new mono Cu (II) and Zn (II) complexes with 2-oxoindole derivatives.
Ragab A; Ammar YA; Ezzat A; Mahmoud AM; Mohamed MBI; El-Tabl AS; Farag RS
Comput Biol Med; 2022 Jun; 145():105473. PubMed ID: 35395516
[TBL] [Abstract][Full Text] [Related]
37. Novel glycosylation zinc(II)-cryptolepine complexes perturb mitophagy pathways and trigger cancer cell apoptosis and autophagy in SK-OV-3/DDP cells.
Zhou Z; Du LQ; Huang XM; Zhu LG; Wei QC; Qin QP; Bian H
Eur J Med Chem; 2022 Dec; 243():114743. PubMed ID: 36116236
[TBL] [Abstract][Full Text] [Related]
38. Spectroscopic, SOD, anticancer, antimicrobial, molecular docking and DNA binding properties of bioactive VO(IV), Cu(II), Zn(II), Co(II), Mn(II) and Ni(II) complexes obtained from 3-(2-hydroxy-3-methoxybenzylidene)pentane-2,4-dione.
Sakthivel A; Thangagiri B; Raman N; Joseph J; Guda R; Kasula M; Mitu L
J Biomol Struct Dyn; 2021 Oct; 39(17):6500-6514. PubMed ID: 32794423
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, characterization, HSA/DNA interactions and antitumor activity of new [Ru(η
Đukić MB; Jeremić MS; Filipović IP; Klisurić OR; Kojić VV; Jakimov DS; Jelić RM; Onnis V; Matović ZD
J Inorg Biochem; 2020 Dec; 213():111256. PubMed ID: 32980642
[TBL] [Abstract][Full Text] [Related]
40. Novel chiral Schiff base Palladium(II), Nickel(II), Copper(II) and Iron(II) complexes: Synthesis, characterization, anticancer activity and molecular docking studies.
Basaran E; Gamze Sogukomerogullari H; Cakmak R; Akkoc S; Taskin-Tok T; Köse A
Bioorg Chem; 2022 Dec; 129():106176. PubMed ID: 36209564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
